Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

NINDS Neuroscience Funding Announcements



Withdrawal of NINDS Participation in PAR-09-251, "Optimization of Small Molecule Probes for the Nervous System (R21)"

Funding Contact(s): Rebecca Farkas, Ph.D.
Funding Categories: Translational Research

Brief Description:

This Notice informs potential applicants that the National Institute of Neurological Disorders and Stroke (NINDS) will no longer accept applications under PAR-09-251, "Optimization of Small Molecule Probes for the Nervous System (R21)," beginning with the February 16, 2012 receipt date. Researchers seeking support for chemical optimization of small molecules probes for preclinical, in vivo proof-of-concept experiments for the purposes of drug discovery should consider PAR-12-060, "Solicitation of Validated Hits for the Discovery of in vivo Chemical Probes (R01)."



NIH Guide: NOT-NS-12-002
Release Date: 2011-12-21
Expiration Date: 2012-09-08